Evidence map›Paper›PMID 30509497›Full record

ArticleBiochemical and biophysical research communications2019

Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice.

Kilan Ashad-Bishop, Koteswararao Garikapati, Linsey E Lindley, Merce Jorda, Karoline J Briegel

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. LncRNAInternational journal of molecular sciences · 2021
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kilan Ashad-BishopSheila and David Fuente Graduate Program in Cancer Biology, University of Miami Miller School of Medicine, Miami, FL, 33136, USA; Department of Surgery, Molecular Oncology Program, University of Miami Miller School of Medicine, Miami, FL, 33136, USA; Braman Family Breast Cancer Institute, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
Koteswararao GarikapatiDepartment of Surgery, Molecular Oncology Program, University of Miami Miller School of Medicine, Miami, FL, 33136, USA; Braman Family Breast Cancer Institute, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
Linsey E LindleyBraman Family Breast Cancer Institute, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
Merce JordaDepartment of Pathology, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
Karoline J BriegelDepartment of Surgery, Molecular Oncology Program, University of Miami Miller School of Medicine, Miami, FL, 33136, USA; Braman Family Breast Cancer Institute, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, 33136, USA. Electronic address: kbriegel@med.miami.edu.
University of Miami · US

Funding

Cell-Intrinsic Regulation of the Mammary Stem Cell NicheR01GM113256 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BRIEGEL, KAROLINE JOSEFINE · 2015 to 2019
$1.5M
NIGMS NIH HHS R01 GM113256
6 · The paper itself

Abstract

WNT/β-catenin signaling plays pivotal roles in mammary development and tumorigenesis; and aberrant activation of this pathway is frequently observed in human breast cancer, correlating with poor outcome. However, the mechanisms underlying WNT-driven mammary tumorigenesis remain incompletely understood. Here, we used mouse mammary tumor virus (MMTV)-Wnt1 transgenic mice, which develop aggressive mammary adenocarcinomas, to examine whether Limb-Bud-and-Heart (LBH) - a WNT/β-catenin target transcription co-factor overexpressed in human triple-negative breast cancers with WNT pathway hyperactivation, contributes to WNT-induced tumorigenesis. We found LBH is specifically overexpressed in basal epithelial tumor cells of MMTV-Wnt1 mammary tumors reminiscent of its basal cell-restricted expression in the normal postnatal mammary gland. To determine the role of LBH in mammary tumorigenesis, we crossed MMTV-Wnt1 mice with basal epithelial-specific Keratin 14/K14-Cre;Lbh

Indexed as

AnimalsCarcinogenesisCell Cycle ProteinsFemaleHyperplasiaMammary Glands, AnimalMammary Neoplasms, AnimalMammary Tumor Virus, MouseMiceMice, TransgenicNuclear ProteinsTranscription FactorsWnt1 ProteinCell Cycle ProteinsLbh protein, mouseNuclear ProteinsTranscription FactorsWnt1 ProteinBreast cancerLimb-Bud-and-HeartMammary tumorigenesisMouse modelWNT/β-catenin signaling

Identifiers

PMID30509497
PMCPMC6368957
OpenAlexW2903546125

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.